BN - Danone S.A.
PAR
->
Consumer Defensive
->
Packaged Foods
Paris,
France
Type: Equity
BN price evolution
BN
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $3270 | $2922 | $3250 | $3275 |
| Inventory | $2464 | $2341 | $2792 | $2619 |
| Total current assets | $13298 | $12916 | $12729 | $12153 |
| Long term investments | ||||
| Property, plant & equipment | $6331 | $6441 | $6614 | $6752 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $45391 | $44486 | $45444 | $45281 |
| Current liabilities | ||||
| Accounts payable | $5155 | $4779 | $5063 | $4899 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $14551 | $13828 | $13999 | $12130 |
| Long term debt | $10084 | $10446 | $10810 | $10806 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $28648 | $28310 | $28941 | $27358 |
| Shareholders' equity | ||||
| Retained earnings | $16202 | $16345 | $16536 | $16666 |
| Other shareholder equity | -$3408 | -$4042 | -$3889 | -$2531 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $659 | $593 | ||
| Short term investments | $5197 | $3680 | ||
| Net receivables | $3809 | $3275 | $3616 | $3362 |
| Inventory | $2341 | $2619 | $1982 | $1840 |
| Total current assets | $12916 | $12153 | $12056 | $10638 |
| Long term investments | $1329 | $1360 | ||
| Property, plant & equipment | $6441 | $6752 | $6843 | $6572 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $44486 | $45281 | $45420 | $42776 |
| Current liabilities | ||||
| Accounts payable | $4779 | $4899 | $3998 | $3467 |
| Deferred revenue | ||||
| Short long term debt | $3077 | $2443 | ||
| Total current liabilities | $13828 | $12130 | $11078 | $10338 |
| Long term debt | $10446 | $10806 | $11770 | $11598 |
| Total noncurrent liabilities | $12273 | |||
| Total debt | ||||
| Total liabilities | $28310 | $27358 | $28045 | $26478 |
| Shareholders' equity | ||||
| Retained earnings | $16345 | $16666 | $18038 | $17374 |
| Other shareholder equity | -$4042 | -$2531 | -$4491 | -$5635 |
| Total shareholder equity | $17273 | $16205 | ||
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13757 | $14167 | $14336 | |
| Cost of revenue | ||||
| Gross Profit | $6792 | $6696 | $6560 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $5047 | $4962 | $4796 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $404 | $429 | $402 | |
| Interest expense | -$96 | -$74 | -$75 | |
| Net income | ||||
| Net income | $1217 | $1087 | $213 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $27619 | $27661 | $24281 | $23620 |
| Cost of revenue | $12267 | |||
| Gross Profit | $12739 | $24281 | $11353 | |
| Operating activities | ||||
| Research & development | $323 | |||
| Selling, general & administrative | $7651 | |||
| Total operating expenses | $24139 | $9356 | $20944 | $20291 |
| Operating income | $3337 | $3329 | ||
| Income from continuing operations | ||||
| EBIT | $3337 | $3329 | ||
| Income tax expense | $768 | $778 | $589 | $762 |
| Interest expense | -$172 | -$153 | -$167 | -$358 |
| Net income | ||||
| Net income | $873 | $945 | $1924 | $1956 |
| Income (for common shares) | $1898 | $1941 | ||
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $132 | -$834 | -$255 | -$749 |
| Financing activities | ||||
| Dividends paid | -$1348 | -$1279 | -$1279 | -$1238 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1984 | -$2057 | -$868 | -$1934 |
| Effect of exchange rate | -$88 | -$503 | -$412 | $112 |
| Change in cash and equivalents | -$437 | $49 | -$111 | $392 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $1924 | $1956 | ||
| Operating activities | ||||
| Depreciation | $1089 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $2967 | |||
| Investing activities | ||||
| Capital expenditures | -$962 | |||
| Investments | $364 | |||
| Total cash flows from investing | -$834 | -$749 | -$610 | |
| Financing activities | ||||
| Dividends paid | -$1279 | -$1238 | -$1385 | |
| Sale and purchase of stock | ||||
| Net borrowings | -$756 | |||
| Total cash flows from financing | -$2057 | -$1934 | -$2360 | |
| Effect of exchange rate | -$503 | $112 | -$48 | |
| Change in cash and equivalents | $49 | $392 | -$51 | |
News
Fundamentals
| Market cap | $49.55B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 643.66M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 106.48% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.91 |
| Quick ratio | 0.74 |